Poseida Therapeutics Inc (PSTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 12-2018 | 09-2013 | 06-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -62,914 | -41,961 | -44,404 | -1,490 | -1,106 |
| Depreciation Amortization | 1,422 | 844 | 1,220 | 1,951 | 1,283 |
| Accounts receivable | N/A | N/A | N/A | -1,241 | -418 |
| Accounts payable and accrued liabilities | -1,043 | 1,413 | N/A | -558 | -199 |
| Other Working Capital | 4,265 | 4,836 | 718 | -1,642 | -217 |
| Other Operating Activity | 10,316 | 6,084 | 4,452 | 2,421 | 1,022 |
| Operating Cash Flow | $-47,954 | $-28,784 | $-38,014 | $-560 | $366 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -48,996 | -18,652 | N/A | N/A | N/A |
| PPE Investments | -3,769 | -1,952 | -1,284 | -1,263 | -701 |
| Investing Cash Flow | $-52,765 | $-20,604 | $-1,284 | $-1,263 | $-701 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 10,000 | 10,000 | N/A | N/A | N/A |
| Common Stock Issued | 4,697 | 4,697 | N/A | 2,013 | 439 |
| Dividend Paid | N/A | N/A | 0 | -427 | -285 |
| Other Financing Activity | 149,660 | 141,797 | 54,068 | 0 | 0 |
| Financing Cash Flow | $164,357 | $156,494 | $54,068 | $1,586 | $154 |
| Beginning Cash Position | 30,395 | 30,395 | 15,625 | 5,177 | 5,177 |
| End Cash Position | 94,033 | 137,501 | 30,395 | 4,941 | 4,996 |
| Net Cash Flow | $63,638 | $107,106 | $14,770 | $-236 | $-181 |
| Free Cash Flow | |||||
| Operating Cash Flow | -47,954 | -28,784 | -38,014 | -560 | 366 |
| Capital Expenditure | -3,769 | -1,952 | N/A | -1,263 | -701 |
| Free Cash Flow | -51,723 | -30,736 | -38,014 | -1,822 | -335 |